Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
1.
Mol Biol (Mosk) ; 50(3): 395-405, 2016.
Artículo en Ruso | MEDLINE | ID: mdl-27414778

RESUMEN

Cancer, along with cardiovascular disorders, is one of the most important problems of healthcare. Pathologies of the hematopoietic system are the most prevalent in patients under 30 years of age, including acute myeloid leukemia (AML), which is widespread and difficult to treat. The review considers the mechanisms that play a significant role in AML cell malignant transformation and shows the contributions of certain genes to both remission and resistance of AML cells to various treatments.


Asunto(s)
Transformación Celular Neoplásica/genética , Regulación Neoplásica de la Expresión Génica , Leucemia Mieloide Aguda/genética , Proteínas de Neoplasias/genética , Transducción de Señal/genética , Antineoplásicos/uso terapéutico , Apoptosis/efectos de los fármacos , Apoptosis/genética , Caspasas/genética , Caspasas/metabolismo , Transformación Celular Neoplásica/metabolismo , Transformación Celular Neoplásica/patología , Resistencia a Antineoplásicos/genética , Granulocitos/efectos de los fármacos , Granulocitos/metabolismo , Granulocitos/patología , Proteínas Hedgehog/genética , Proteínas Hedgehog/metabolismo , Humanos , Leucemia Mieloide Aguda/tratamiento farmacológico , Leucemia Mieloide Aguda/metabolismo , Leucemia Mieloide Aguda/patología , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Mitocondrias/patología , Proteínas de Neoplasias/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Inducción de Remisión , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo
2.
Mol Biol (Mosk) ; 49(6): 1048-51, 2015.
Artículo en Ruso | MEDLINE | ID: mdl-26710789

RESUMEN

In this study we evaluated c-kit, VEGFA, and MYC gene expression level in seven neuroblastoma stable cell lines: SK-N-SH, SK-N-BE, SK-N-AS, SH-SY5Y, Kelly, IMR-32, and LAN-1. Expression levels of these genes can serve as diagnostic factors of cancer progression, and proteins encoded by these genes are promising targets for neuroblastoma treatment. SH-SY5Y and SK-N-AS cells have highest MYC expression and the same VEGFA expression, although SH-SY5Y has 10 times higher c-kit expression than SK-N-AS cells. Both IMR-32 and LAN-1 cells have low MYC expression level, but differ in c-kit expression, IMR-32 has significantly higher c-kit expression, than any other neuroblastoma cell line. LAN-1 on the other hand has the highest VEGFA expression. These data suggest that MYC, c-kit, and VEGFA genes can play different roles in development and progression of neuroblastoma depending on other activated molecular mechanisms in malignant cells.


Asunto(s)
Regulación Neoplásica de la Expresión Génica , Neuroblastoma/metabolismo , Línea Celular Tumoral , Humanos , Neuroblastoma/genética , Proteínas Proto-Oncogénicas c-kit/genética , Proteínas Proto-Oncogénicas c-kit/metabolismo , Proteínas Proto-Oncogénicas c-myc/genética , Proteínas Proto-Oncogénicas c-myc/metabolismo , Factor A de Crecimiento Endotelial Vascular/genética , Factor A de Crecimiento Endotelial Vascular/metabolismo
3.
Leukemia ; 28(11): 2222-8, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24727677

RESUMEN

The t(8;21)(q22;q22) rearrangement represents the most common chromosomal translocation in acute myeloid leukemia (AML). It results in a transcript encoding for the fusion protein AML1-ETO (AE) with transcription factor activity. AE is considered to be an attractive target for treating t(8;21) leukemia. However, AE expression alone is insufficient to cause transformation, and thus the potential of such therapy remains unclear. Several genes are deregulated in AML cells, including KIT that encodes a tyrosine kinase receptor. Here, we show that AML cells transduced with short hairpin RNA vector targeting AE mRNAs have a dramatic decrease in growth rate that is caused by induction of apoptosis and deregulation of the cell cycle. A reduction in KIT mRNA levels was also observed in AE-silenced cells, but silencing KIT expression reduced cell growth but did not induce apoptosis. Transcription profiling of cells that escape cell death revealed activation of a number of signaling pathways involved in cell survival and proliferation. In particular, we find that the extracellular signal-regulated kinase 2 (ERK2; also known as mitogen-activated protein kinase 1 (MAPK1)) protein could mediate activation of 23 out of 29 (79%) of these upregulated pathways and thus may be regarded as the key player in establishing the t(8;21)-positive leukemic cells resistant to AE suppression.


Asunto(s)
Apoptosis/genética , Subunidad alfa 2 del Factor de Unión al Sitio Principal/genética , Regulación Leucémica de la Expresión Génica , Leucemia Mieloide Aguda/genética , Proteínas de Fusión Oncogénica/genética , Proteínas Proto-Oncogénicas c-kit/genética , Transducción de Señal/genética , Ciclo Celular/genética , Línea Celular Tumoral , Proliferación Celular , Regulación hacia Abajo/genética , Células HEK293 , Humanos , Leucemia Mieloide Aguda/patología , Modelos Genéticos , ARN Interferente Pequeño/genética , Proteína 1 Compañera de Translocación de RUNX1
4.
Sci Rep ; 4: 3742, 2014 Jan 17.
Artículo en Inglés | MEDLINE | ID: mdl-24434734

RESUMEN

The structure of the [001]-oriented single crystalline tungsten probes sharpened in ultra-high vacuum using electron beam heating and ion sputtering has been studied using scanning and transmission electron microscopy. The electron microscopy data prove reproducible fabrication of the single-apex tips with nanoscale pyramids grained by the {011} planes at the apexes. These sharp, [001]-oriented tungsten tips have been successfully utilized in high resolution scanning tunneling microscopy imaging of HOPG(0001), SiC(001) and graphene/SiC(001) surfaces. The electron microscopy characterization performed before and after the high resolution STM experiments provides direct correlation between the tip structure and picoscale spatial resolution achieved in the experiments.

5.
Mol Biol (Mosk) ; 48(2): 344-8, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25850304

RESUMEN

Here we describe a system based on recombinant lentiviral vectors for the safe screening of potential anti-HIV drugs. The system allows to evaluate the sensitivity of HIVl-1 reverse transcriptase and integrase (wild-type as well as mutant forms of these enzymes detected in drug-resistant virus isolates) towards different drugs and substances, but also to screen inhibitors of other stages of HIV-1 life cycle.


Asunto(s)
Fármacos Anti-VIH/farmacología , Inhibidores de Integrasa VIH/farmacología , VIH-1/efectos de los fármacos , Ensayos Analíticos de Alto Rendimiento , Replicación Viral/efectos de los fármacos , Farmacorresistencia Viral , Citometría de Flujo , Expresión Génica , Genes Reporteros , Vectores Genéticos , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Células HEK293 , Integrasa de VIH/genética , Integrasa de VIH/metabolismo , Transcriptasa Inversa del VIH/antagonistas & inhibidores , Transcriptasa Inversa del VIH/genética , Transcriptasa Inversa del VIH/metabolismo , VIH-1/enzimología , VIH-1/genética , Humanos , Lentivirus/genética , Transducción Genética , Virión/efectos de los fármacos , Virión/crecimiento & desarrollo
6.
Mol Biol (Mosk) ; 47(2): 282-5, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-23808162

RESUMEN

Acute myeloid leukemia is the most common acute leukemia affecting adults, and its incidence increases with age. Along with chromosomal translocations in leukemic cells mutations in the genes of receptor tyrosine kinases KIT and FLT3 were found with a high frequency. Here we show that transgenic progenitor of B-cells BAF3/FLT3-ITD are much more sensitive to the ribonuclease binase cytotoxic effects than the original BAF3 cells. The principal difference between BAF3/FLT3-ITD and the original BAF3 cells is the expression of FLT3-ITD oncogene, which leads to a change in the normal cell signaling pathways. Earlier, we described a similar effect for the cytotoxic action of binase on Kasumi-1 and FDC-P1-N822K cells, which express the activated KIT-N822K oncogene. Increased binase cytotoxicity toward the cells, expressing FLT3-ITD oncogene, suggests that, as in the case of FDC-P1 cells, transduced by KIT oncogene, the expression of an activated oncogene determines the sensitivity of cells to binase.


Asunto(s)
Endorribonucleasas/metabolismo , Leucemia Mieloide Aguda/genética , Células Precursoras de Linfocitos B/enzimología , Tirosina Quinasa 3 Similar a fms/genética , Animales , Proliferación Celular , Transformación Celular Neoplásica/genética , Endorribonucleasas/genética , Regulación Leucémica de la Expresión Génica , Humanos , Leucemia Mieloide Aguda/patología , Ratones , Ratones Transgénicos , Mutación , Células Precursoras de Linfocitos B/metabolismo , Proteínas Proto-Oncogénicas c-kit/metabolismo , Transducción de Señal , Tirosina Quinasa 3 Similar a fms/metabolismo
8.
Mol Biol (Mosk) ; 47(5): 853-60, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-25509358

RESUMEN

Currently, neutron capture therapy is a promising cancer treatment. This method is based on the reaction of the thermal neutron capture by some non-radioactive elements (e.g., Gds57), which results in subsequent emission of electrons and gamma rays. An effective instrument for delivery of gadolinium into the tumor tissue are the particles of the "rigid" nanostructures (NS) based on double-stranded DNA complexes with gadolinium (NS-Gd). The local concentration of Gd in such nanostructures may reach 40%. To optimize the process of neutron capture therapy it is very important to investigate possible penetration mechanisms of NS-Gd particles into the tumor cells. In this work, the dynamics of interaction NS-Gd with cultivated chinese hamster ovary cells (CHO) was studied by confocal and electron microscopy. It is shown that NS-Gd are able to enter CHO cells. This process begins in about 1 hour after the start ofincubation. After 6 h NS-Gd particles were detected in almost all cells. A further increase of the incubation time does not lead to significant changes in cell morphology, although the number NS-Gd inside the cells increases. The plasma membrane of the cells remains intact. The NS-Gd particles, which entered the cells, remain inside the cells for a long time. The data obtained show that NS-Gd are relatively low-toxic and suggest that the presence of NS-Gd in the tumor cells does not prevent their division. The data obtained are important for improving the efficiency of the neutron capture therapy method.


Asunto(s)
ADN/química , Gadolinio/química , Nanopartículas/química , Neoplasias/terapia , Terapia por Captura de Neutrón , Animales , Células CHO , Cricetinae , Cricetulus , ADN/uso terapéutico , Electrones , Gadolinio/uso terapéutico , Rayos gamma , Humanos , Nanopartículas/uso terapéutico , Neoplasias/patología
9.
Mol Biol (Mosk) ; 44(5): 876-88, 2010.
Artículo en Ruso | MEDLINE | ID: mdl-21090242

RESUMEN

In the present study we have applied the siRNA approach for substantial reduction of AML1-ETO and RUNX1 (K83N) expression, which are frequently found in the leukemic cells. We have designed small hairpin RNAs (shRNA) for targeting AML1-ETO oncogene and a region close to the 5'-untranslated region of mRNA for the mutant RUNX1 (K83N) oncogene and expressed the shRNAs in lentiviral vectors. We report a stable reduction in expression of the oncogenes following the introduction of shRNAs into cells.


Asunto(s)
Subunidad alfa 2 del Factor de Unión al Sitio Principal/biosíntesis , Regulación hacia Abajo , Regulación Leucémica de la Expresión Génica , Leucemia/metabolismo , Mutación Missense , Proteínas de Fusión Oncogénica/biosíntesis , Interferencia de ARN , Regiones no Traducidas 5'/genética , Sustitución de Aminoácidos , Animales , Línea Celular Tumoral , Subunidad alfa 2 del Factor de Unión al Sitio Principal/antagonistas & inhibidores , Subunidad alfa 2 del Factor de Unión al Sitio Principal/genética , Células HEK293 , Humanos , Leucemia/genética , Ratones , Proteínas de Fusión Oncogénica/antagonistas & inhibidores , Proteínas de Fusión Oncogénica/genética , ARN Interferente Pequeño/genética , ARN Interferente Pequeño/metabolismo , Proteína 1 Compañera de Translocación de RUNX1
10.
Patol Fiziol Eksp Ter ; (4): 7-8, 1994.
Artículo en Ruso | MEDLINE | ID: mdl-7700709

RESUMEN

The results of reperfusion coronary circulatory alterations manifested by a rapid cessation of reactive hyperemia and a secondary increase in coronary vascular resistance were studied in acute canine experiments on a model of partial blood flow restriction by 30,, 50, 70, and 90% with subsequent reperfusion. It was shown that most frequently delayed disturbances of myocardial blood supply adequacy, which is qualified as a reperfusion coronarogenic mechanism of secondary coronary failure progression, which differs from the well-known phenomenon of unrestored coronary blood flow, which occurs after blood flow restriction to a greater extent.


Asunto(s)
Circulación Coronaria/fisiología , Daño por Reperfusión Miocárdica/fisiopatología , Animales , Perros , Femenino , Masculino
12.
Kardiologiia ; 32(6): 63-5, 1992 Jun.
Artículo en Ruso | MEDLINE | ID: mdl-1405300

RESUMEN

Coronary insufficiency of various degrees was reproduced in experiments with anesthetized dogs by using coronary artery catheterization by progressively limiting the regional blood flow by 30, 50, 70, and 90%, the dog chest being closed. The specific features of regulatory reactions of cardiac vessels were also studied under subsequent reperfusion. It was shown that regulation of coronary circulation became changed in most cases after markedly limited coronary blood flow, as manifested by impaired reperfusion hyperemia and its rapid cessation that prevented the "payment" of blood flow debt and a secondary increase of cardiac vascular resistance above the preocclusive level. There was a significant relationship between the detected disorders and the degree of prior limited coronary perfusion.


Asunto(s)
Circulación Coronaria , Reperfusión Miocárdica , Animales , Perros , Hiperemia/etiología , Daño por Reperfusión Miocárdica , Factores de Tiempo
13.
Kardiologiia ; 31(1): 10-3, 1991 Jan.
Artículo en Ruso | MEDLINE | ID: mdl-2046233

RESUMEN

Coronary failure was demonstrated to be followed by impaired coronary circulation regulation in the hypoperfused area, as manifested by quantitative (incomplete realization of dilator reserve) or qualitative (greater coronary resistance) alterations of coronary responses to ischemia. The disorders detected were shown to be directly related to the manifestations of limited coronary flow, predominant with its 70% decrease and represent an essential mechanism of further progression of coronary failure.


Asunto(s)
Circulación Coronaria/fisiología , Enfermedad Coronaria/fisiopatología , Vasos Coronarios/fisiopatología , Modelos Animales de Enfermedad , Contracción Miocárdica/fisiología , Animales , Enfermedad Coronaria/etiología , Perros , Índice de Severidad de la Enfermedad , Resistencia Vascular/fisiología
18.
Farmakol Toksikol ; 50(2): 97-9, 1987.
Artículo en Ruso | MEDLINE | ID: mdl-3582645

RESUMEN

In acute experiments on dogs it was shown that under the conditions of a moderate (by 30 and 50%) decrease of the coronary blood flow, a quantitative and qualitative dissociations of changes in adrenergic reactions of the heart and coronary vessels to isadrin and noradrenaline occur--this was manifested by a distinct suppression of dilatational coronary reactions with a less pronounced suppression or even enhancement of adrenergic effects of the heart.


Asunto(s)
Enfermedad Coronaria/fisiopatología , Vasos Coronarios/fisiopatología , Corazón/fisiopatología , Receptores Adrenérgicos/fisiología , Animales , Circulación Coronaria/efectos de los fármacos , Vasos Coronarios/efectos de los fármacos , Perros , Corazón/efectos de los fármacos , Isoproterenol/farmacología , Norepinefrina/farmacología , Receptores Adrenérgicos/efectos de los fármacos , Vasodilatación/efectos de los fármacos
19.
Kardiologiia ; 26(5): 85-8, 1986 May.
Artículo en Ruso | MEDLINE | ID: mdl-3735925

RESUMEN

Relationship between the realization of the coronary dilatation reserve and cardiac contractility was investigated in acute dog experiments with the intact thoracic cage under partially limited and rationed flow through a major coronary artery (a 30-minute 70% reduction), and during subsequent reperfusion. Limited coronary flow was seen in combination with moderately depressed cardiac contractility that did not improve significantly during the reperfusion period of equal duration. Inadequate realization of the coronary dilatation reserve that fails to restore the balance between blood supply and myocardial oxygen requirement may be a cause of incomplete recovery during the early reperfusion period.


Asunto(s)
Enfermedad Coronaria/fisiopatología , Vasos Coronarios/fisiopatología , Contracción Miocárdica , Adaptación Fisiológica , Animales , Perros , Insuficiencia Cardíaca/etiología , Factores de Tiempo , Resistencia Vascular
20.
Biull Eksp Biol Med ; 101(5): 534-6, 1986 May.
Artículo en Ruso | MEDLINE | ID: mdl-3708130

RESUMEN

The studies were performed on anesthetized dogs using the model of partial controlled blood flow restriction in the left circumflex coronary artery with intact thorax. 70% of blood flow restriction were compensated by coronary vasodilation reserve, evaluated in hyperemia reaction. No rapid reperfusion hyperemia reaction was observed in reperfusion period, while moderate reduction in heart contractility was maintained. Alterations in coronary vessel reactivity could have a certain depressing effect on reperfusion hyperemia reaction. The observed changes were reversible, as coronary vessels retained their dilatation ability in response to an additional ischemic stimulus.


Asunto(s)
Circulación Coronaria , Enfermedad Coronaria/fisiopatología , Hiperemia/fisiopatología , Vasodilatación , Animales , Perros , Contracción Miocárdica , Perfusión , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...